Company intelligence
Gyala Therapeutics
Developing new cell therapies for hematological malignancies.
Biotechnology Research
Barcelona, ES
8 employees
Founded 2020
1 public signals
About Gyala Therapeutics
Gyala Therapeutics is a spin off from Hospital Clínic – IDIBAPS (Barcelona) focused on developing new CAR-T therapies for treating hematological malignancies. We raised raised around €8 million to date through equity investment from Invivo Partners, Nara Capital, and CDTI Innvierte, as well as non-dilutive funding from national innovation programs including NEOTEC and Public-Private Collaboration Projects.
Verified activity
Signals from Gyala Therapeutics
1 published signal